cultured, partially T-Cell depleted, allogenic thymic tissue for transplantation | |
---|---|
Trade Name | |
Orphan Indication | DiGeorge syndrome |
USA Market Approval | USA |
USA Designation Date | 2003-08-15 00:00:00 |
Sponsor | Enzyvant Therapeutics GmbH;Viaduktstrasse 8, CH-4051 Basel; |
Related Access Program